Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Article Types

Countries / Regions

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Search Results (218)

Search Parameters:
Keywords = leprosy

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
24 pages, 7943 KB  
Article
Clofazimine Treatment Modulates Key Non-Coding RNAs Associated with Tumor Progression and Drug Resistance in Lethal Prostate Cancer
by Sarah Batten, Harish Kumar, Jeremiah Pfitzer, Daniel Chinedu Nweze, Suman Mazumder, Robert D. Arnold, Panagiotis Mistriotis, Taraswi Mitra Ghosh and Amit Kumar Mitra
Int. J. Mol. Sci. 2025, 26(22), 10892; https://doi.org/10.3390/ijms262210892 - 10 Nov 2025
Viewed by 206
Abstract
Metastatic castration-resistant prostate cancer/PCa (mCRPC) is a clinically advanced form of PCa that is associated with increased aggressiveness, cancer stemness, morbidity, and the risk of developing resistance to taxanes, currently the first-line chemotherapy for mCRPC. Clofazimine (CLF) is a potential immunomodulator drug that [...] Read more.
Metastatic castration-resistant prostate cancer/PCa (mCRPC) is a clinically advanced form of PCa that is associated with increased aggressiveness, cancer stemness, morbidity, and the risk of developing resistance to taxanes, currently the first-line chemotherapy for mCRPC. Clofazimine (CLF) is a potential immunomodulator drug that is FDA-approved for the treatment of leprosy. Recently, using in vitro, in vivo, and ex vivo models, we established the efficacy of CLF in chronic myeloid leukemia and multiple myeloma. Here, we demonstrate that CLF is effective as a single agent and in combination with taxanes in a panel of cell lines representing the diversity of CRPC patients. Using a microfluidic assay, we showed the impact of CLF on cancer cell migration and metastatic potential. Further, we also found that CLF reduces ALDH activity—a marker for cancer ‘stem-like’ cells (CSCs), a subtype of cancer cells with self-renewal and differentiation capacities (epithelial-to-mesenchymal transdifferentiation/EMT). Bulk and single-cell RNAseq followed by functional validation and in silico analysis showed that CLF treatment is associated with apoptosis, ER stress, oxidative phosphorylation, and mitochondrial dysfunction. Most importantly, CLF modulates the expression of several non-coding RNAs, including MALAT1 and NEAT1, that are linked to tumor cell proliferation, cell migration, and drug resistance. Full article
(This article belongs to the Special Issue Roles of Non-Coding RNAs in Cancer)
Show Figures

Figure 1

13 pages, 1080 KB  
Article
Risk Factors of Pulmonary Tuberculosis in Aseer Region, Saudi Arabia: A Case–Control Study
by Faris Saeed Alsulayyim, Abdullah Abdulmohsen Alsabaani, Mohammad Abdullah Garnan, Amna Babiker Alshash, Asim Abdelwahid Elnoor Ali, Mohammed Awthah Aldail, Mazen Ali Asiri, Faten Ali Nasser and Syed Esam Mahmood
Healthcare 2025, 13(21), 2755; https://doi.org/10.3390/healthcare13212755 - 30 Oct 2025
Viewed by 233
Abstract
Background: Tuberculosis (TB) constitutes one of the leading causes of morbidity and mortality worldwide. Due to adopted prevention measures, good public health practices, and better treatment, its incidence, prevalence, and case fatality rates steadily fell. Objectives and Methods: Following a case–control research design, [...] Read more.
Background: Tuberculosis (TB) constitutes one of the leading causes of morbidity and mortality worldwide. Due to adopted prevention measures, good public health practices, and better treatment, its incidence, prevalence, and case fatality rates steadily fell. Objectives and Methods: Following a case–control research design, this study aimed to explore the risk factors of pulmonary TB among patients registered in the Aseer Region, Saudi Arabia. This study included 105 active TB cases (study group) and 143 (control group) who were randomly recruited from those attending the vaccination units at Primary Healthcare Centers in Aseer. Results: Participants differed significantly according to their nationality (with 65.7% being Saudi in the TB group compared with 89.5% Saudi nationals in the control, p < 0.001); educational status (with 27.6% being university graduates in the TB group compared with 53.8% in the control, p < 0.001); marital status, with most TB patients being single, compared with control (70.5%, and 44.1%, p < 0.001); monthly income, with lower income <5000 Saudi Riyals (SRs), among TB patients than control subjects (80% and 44.1%, p < 0.001); and body mass index (20% of the TB patients were underweight, compared with 6.3% in the control, p < 0.001). Also, participants differed significantly according to their residence, with more rural residence among TB patients than control (18.1% and 7%, p = 0.007), and type of houses, with 84.8% of TB patients living in apartments, compared to 68.5% of the control (p < 0.001). The binary logistic regression model of the possible risk factors related to pulmonary TB revealed that nationality, residence, and body mass index were the only significant independent risk factors (p < 0.001, p = 0.007, and p < 0.001). Conclusions: Personal characteristics of pulmonary TB patients include being non-Saudi, less educated, not married, unemployed, with a low monthly income, and being underweight. Risk factors related to place included residing in rural areas and living in the basement of a rented apartment. Full article
Show Figures

Figure 1

15 pages, 2242 KB  
Article
Historical and Contemporary Evidence Confirms a Higrevirus as the Causal Agent of Citrus Zonate Chlorosis in Brazil
by Laura R. Pereira, Mariane C. Rodrigues, Camila Chabi-Jesus, Pedro L. Ramos-González, Cristiane J. Barbosa, Magno G. Santos, Helcio Costa, Luana C. Maro, Aline D. Tassi, Elliot W. Kitajima, Ricardo Harakava and Juliana Freitas-Astúa
Viruses 2025, 17(11), 1428; https://doi.org/10.3390/v17111428 - 28 Oct 2025
Viewed by 304
Abstract
Citrus leprosis (CL) and citrus zonate chlorosis (ZC) were first described in Brazil in the 1930s. Both diseases, which caused non-systemic lesions primarily characterized by chlorotic and/or necrotic spots, were associated with the presence of Brevipalpus mites. While CL has since been well [...] Read more.
Citrus leprosis (CL) and citrus zonate chlorosis (ZC) were first described in Brazil in the 1930s. Both diseases, which caused non-systemic lesions primarily characterized by chlorotic and/or necrotic spots, were associated with the presence of Brevipalpus mites. While CL has since been well characterized as being caused by viruses of the genera Cilevirus (family Kitaviridae) and Dichorhavirus (family Rhabdoviridae) and transmitted by several species of Brevipalpus mites, the causal agent of ZC remained unknown. In this study, we analyzed Citrus spp. samples exhibiting typical ZC symptoms using high-throughput sequencing (HTS) to determine the etiology of ZC. We examined historical herbarium specimens collected between 1933 and 1965 alongside fresh samples collected from 2016 to 2022. Our results identified the higrevirus hibiscus green spot virus 2 (HGSV2, Higrevirus waimanalo) as the causal agent of ZC. In addition, we report for the first time the presence of a higrevirus in continental America, expand the diversity of known kitaviruses infecting citrus in Brazil, and demonstrate the transmission of an higrevirus by Brevipalpus yothersi and B. papayensis. Full article
Show Figures

Graphical abstract

18 pages, 2767 KB  
Article
Tuberculosis Preventive Treatment in People Living with HIV in Uganda: Facilitators and Barriers for Initiation and Completion
by Ritah Mande, Pruthu Thekkur, Denis Mudoola, Joseph Nsonga, John Paul Dongo, Simon Muchuro, Stavia Turyahabwe, Henry Luzze, Proscovia Namuwenge, Selma Dar Berger, Deus Lukoye, Macarthur Charles, Odile Ferroussier-Davis and Riitta A. Dlodlo
Trop. Med. Infect. Dis. 2025, 10(11), 303; https://doi.org/10.3390/tropicalmed10110303 - 27 Oct 2025
Viewed by 455
Abstract
Tuberculosis preventive treatment (TPT) is a mainstay for reducing the tuberculosis (TB) burden among people living with human immunodeficiency virus (PLHIV). Context-specific challenges hinder TPT uptake and completion among PLHIV. During 2022–2024, a mixed-methods design was used to evaluate the TPT cascade and [...] Read more.
Tuberculosis preventive treatment (TPT) is a mainstay for reducing the tuberculosis (TB) burden among people living with human immunodeficiency virus (PLHIV). Context-specific challenges hinder TPT uptake and completion among PLHIV. During 2022–2024, a mixed-methods design was used to evaluate the TPT cascade and explore its facilitators and barriers among PLHIV availing care from 12 PEPFAR-supported health facilities in Uganda. The quantitative component included analysis of routine programmatic data, and the qualitative component included focus group discussions and in-depth interviews with healthcare workers and PLHIV. A total of 1349 PLHIV were enrolled in the evaluation. Among PLHIV newly initiated on ART (≤3 months), 74% started TPT, and 98% of them completed it. In PLHIV already on ART, 87% had initiated TPT (76% before and 11% during this evaluation), with a treatment completion rate of 98%. The facilitators for TPT implementation included access to shorter TPT regimens, integration of services, and adherence counseling. Barriers included knowledge gaps, pill burden, TPT drug stock-outs, and documentation inconsistencies. The TPT completion rate was higher than the national target (90%), but the TPT initiation remains low. Improved access to shorter regimens, adherence counseling, better documentation, and service integration can sustain the completion rate and improve the initiation rate in Uganda and possibly elsewhere. Full article
(This article belongs to the Special Issue New Perspectives in Tuberculosis Prevention and Control)
Show Figures

Figure 1

31 pages, 1480 KB  
Review
Overcoming Treatment Challenges in HIV-Associated Mycobacterial Diseases: New Therapeutic Frontiers
by Omid Nikjeh, Seyedehparmis Rejali, Kayvan Sasaninia and Vishwanath Venketaraman
Int. J. Mol. Sci. 2025, 26(21), 10325; https://doi.org/10.3390/ijms262110325 - 23 Oct 2025
Viewed by 497
Abstract
For drug-susceptible TB, the WHO-endorsed first-line regimen (isoniazid, rifampicin, ethambutol, pyrazinamide) remains the global reference. Therapy must always be tailored to drug susceptibility, especially in MDR- and XDR-TB. HIV-associated mycobacterial infections—including Mycobacterium tuberculosis (TB), disseminated Mycobacterium avium complex (MAC), and Mycobacterium leprae ( [...] Read more.
For drug-susceptible TB, the WHO-endorsed first-line regimen (isoniazid, rifampicin, ethambutol, pyrazinamide) remains the global reference. Therapy must always be tailored to drug susceptibility, especially in MDR- and XDR-TB. HIV-associated mycobacterial infections—including Mycobacterium tuberculosis (TB), disseminated Mycobacterium avium complex (MAC), and Mycobacterium leprae (M. leprae)—remain leading causes of morbidity and mortality in people living with HIV (PLWH). TB continues to account for the highest burden of AIDS-related deaths worldwide, while MAC and leprosy complicate care in advanced immunosuppression. This review synthesizes current evidence on epidemiology, clinical features, and management challenges of HIV–mycobacterial co-infections. We discuss drug-susceptible and drug-resistant TB therapies, drug–drug interactions with antiretroviral therapy (ART), and the clinical impact of immune reconstitution inflammatory syndrome (IRIS). Beyond established regimens, we highlight host-directed strategies such as metformin, glutathione augmentation, mTOR modulation, and vitamin D; immunotherapies including interferon-γ, GM-CSF, and IL-7; and therapeutic vaccines (M72/AS01E, MTBVAC, VPM1002) as promising adjuncts. Distinct from guideline-focused overviews, this review emphasizes non-tuberculous mycobacterial disease (NTM, including MAC) and leprosy in PLWH and synthesizes host-directed and adjunctive strategies with their translational prospects, including ART compatibility and IRIS. By integrating TB, NTM, and leprosy across the HIV care continuum, we highlight opportunities not treated in detail elsewhere—particularly HDT-enabled approaches and implementation considerations in PLWH. Full article
(This article belongs to the Special Issue Advances in Molecular Therapeutics for HIV Co-Infections)
Show Figures

Figure 1

16 pages, 4135 KB  
Article
IDO-Mediated Immune and Metabolic Dysregulation in Schwann Cells Exposed to Mycobacterium leprae
by Atta Ur Rahman, Raíssa Couto Santana, Mylena Masseno de Pinho Pereira, Claudia Luciana dos Santos Moura, Débora Santos da Silva, Otto Castro Araujo, Thyago Leal-Calvo, Isabela Espasandin, Tatiana Pereira da Silva, Euzenir Nunes Sarno, Bruno Jorge de Andrade Silva, Rubem Sadok Figueiredo Menna-Barreto, Márcia Maria Jardim, Cristiana Santos de Macedo, Flávio Alves Lara and Roberta Olmo Pinheiro
Cells 2025, 14(19), 1550; https://doi.org/10.3390/cells14191550 - 3 Oct 2025
Viewed by 663
Abstract
Leprosy is a chronic infectious disease that targets the peripheral nervous system, leading to peripheral neuropathy. Mycobacterium leprae primarily infects Schwann cells, adipocytes, and macrophages, altering their metabolism and gene expression. This study investigates the metabolic interaction between M. leprae and Schwann cells, [...] Read more.
Leprosy is a chronic infectious disease that targets the peripheral nervous system, leading to peripheral neuropathy. Mycobacterium leprae primarily infects Schwann cells, adipocytes, and macrophages, altering their metabolism and gene expression. This study investigates the metabolic interaction between M. leprae and Schwann cells, with a focus on indoleamine 2,3-dioxygenase (IDO), a key enzyme in tryptophan catabolism via the kynurenine pathway. We found that M. leprae induces IDO expression in Schwann cells, suggesting a role in immune modulation and neuropathy. Inhibition of IDO with 1-methyl-L-tryptophan (1-MT) reduced Schwann cell viability and metabolic activity in response to M. leprae. After 24 h of infection, M. leprae impaired mitochondrial membrane potential, although no significant changes in autophagy or mitochondrial ultrastructure were observed by electron microscopy. Interestingly, IDO1 inhibition upregulated the expression of antioxidant genes, including GPX4, NFE2L2, and HMOX1. In conclusion, these findings highlight a central role for IDO in shaping the metabolic and immunological response of Schwann cells to M. leprae infection. IDO induction contributes to immune regulation and cellular stress, while its inhibition disrupts cell viability and promotes antioxidant gene expression. These results position IDO as a potential therapeutic target for modulating host–pathogen interactions and mitigating nerve damage in leprosy. Full article
(This article belongs to the Section Cells of the Nervous System)
Show Figures

Figure 1

15 pages, 2002 KB  
Article
Tissue Expression of NGF in Skin Lesions of HIV-Coinfected and Non-Coinfected Leprosy Patients and Its Relationship with Leprosy Neural Damage
by Marília Brasil Xavier, Lucas dos Santos Fontes, Mariana Garcia Borges do Nascimento, Simone Rodrigues dos Passos, Débora Pinheiro Xavier, Larissa dos Santos Alcantara, Elza Baía de Brito, Cláudia Maria de Castro Gomes and Carlos Eduardo Pereira Corbett
Microorganisms 2025, 13(10), 2271; https://doi.org/10.3390/microorganisms13102271 - 27 Sep 2025
Viewed by 455
Abstract
Leprosy remains a significant public health issue, particularly due to its neuropathic consequences, which affect sensory, motor, and autonomic functions, leading to severe disabilities. HIV/AIDS, another major public health concern, overlaps geographically with leprosy and is also associated with peripheral neuropathies, complicating the [...] Read more.
Leprosy remains a significant public health issue, particularly due to its neuropathic consequences, which affect sensory, motor, and autonomic functions, leading to severe disabilities. HIV/AIDS, another major public health concern, overlaps geographically with leprosy and is also associated with peripheral neuropathies, complicating the management of co-infected patients. Understanding how Nerve Growth Factor (NGF) is regulated in leprosy and HIV-leprosy co-infection may contribute to immunomodulatory treatments and neuroimmune response control. A cross-sectional study evaluated NGF tissue expression using immunohistochemistry in 47 HIV/leprosy co-infected patients and 61 leprosy-only patients. The co-infected group had a higher incidence of neuritis (40.4%) and a prevalence of exclusively reversal reactions. However, the occurrence of neuritis was not associated with higher expression of NGF in the tissue. Leprosy reactions were more prevalent in non-co-infected patients with multibacillary forms (50%). Multibacillary forms in both groups of patients showed higher cellular expression of NGF, with a greater tendency for higher NGF expression in non-co-infected multibacillary patients (p = 0.0021), suggesting impairment in the immune response involved in the tissue expression of neurotrophins in the co-infected group. Overall, co-infection with HIV did not influence the increase in NGF in the lesions of leprosy patients compared with patients with leprosy alone. Full article
(This article belongs to the Special Issue Mycobacterium leprae, Mycobacterium lepromatosis and Leprosy Studies)
Show Figures

Figure 1

9 pages, 1003 KB  
Article
Assessing the Feasibility of an Intensified Extended Contact Survey (IECS) Compared to Passive Household Screening for Leprosy in Bangladesh
by Kazi Naher, Mahfuza Rifat, Dipak Kumar Biswas, Sheikh Mohammad Faisal, Nimer Ortuño-Gutiérrez and Epco Hasker
Trop. Med. Infect. Dis. 2025, 10(10), 274; https://doi.org/10.3390/tropicalmed10100274 - 24 Sep 2025
Viewed by 551
Abstract
Bangladesh is among the 23 WHO priority countries for leprosy, with a new case detection rate of 21 per million population including children among new cases indicating recent transmission. We aimed to compare active versus passive case detection using geospatial tools. A cluster-randomized [...] Read more.
Bangladesh is among the 23 WHO priority countries for leprosy, with a new case detection rate of 21 per million population including children among new cases indicating recent transmission. We aimed to compare active versus passive case detection using geospatial tools. A cluster-randomized study was conducted across seven intervention and seven control districts. In the intervention arm, GPS coordinates of new cases were recorded, and contacts within a 75-m buffer were screened. Spatial cluster analysis using Kulldorff’s scan statistics was performed to identify hotspots. The main objective was to achieve early case detection in intervention areas, reflected in a lower proportion of new patients with grade 2 disabilities (G2Ds). A total of 347/382 (90%) index cases were enrolled in the intervention arm, compared to 380/462 (82%) in the control arm. Among household contacts, 7/1482 (5‰) new cases were found in the intervention area and 12/1565 (7.7‰) in the control area. Additionally, 18/25,720 (0.7‰) new cases were detected among neighbor contacts in the intervention arm. G2D proportions were not lower in the intervention arm (15%) than in the comparator arm (11%, p = 0.043). Comparable household contact cases were observed in both arms, with more cases emerging among neighbors in intervention districts. Eight spatial clusters were identified, including 288/844 (34%) index cases, with three significant clusters from 2022 to 2023. Screening within a 75-m buffer detected additional leprosy cases, though fewer than expected due to COVID-19 limitations. Targeting clusters for case detection and prophylaxis could strengthen transmission control efforts. Full article
(This article belongs to the Section Neglected and Emerging Tropical Diseases)
Show Figures

Figure 1

15 pages, 5640 KB  
Article
Visual Detection of Malaria Parasite-Parasitized Erythroblasts in Peripheral Blood via Immunization-Based Model
by Kumpei Ito, Yuki S. Tateishi, Takashi Imai, Shinya Miyazaki, Yukiko Miyazaki, Wataru Kagaya, Mai Nakashima, Miho Sase, Misato Yoshioka-Takeda, Chikako Shimokawa, Kyoko Hayashi, Kentaro Itokawa, Osamu Komagata, Ha Ngo-Thanh, Aoi Shimo, Tamasa Araki, Takeshi Annoura, Takashi Murakami and Hajime Hisaeda
Vaccines 2025, 13(9), 988; https://doi.org/10.3390/vaccines13090988 - 21 Sep 2025
Viewed by 777
Abstract
Background: Erythroblasts have recently been identified as host cells for malarial parasites, revealing a previously underappreciated host–parasite interaction. However, their extremely low abundance in peripheral blood has hindered progress, especially in elucidating the biological significance of parasitized erythroblasts (pEBs) in vivo. Methods: [...] Read more.
Background: Erythroblasts have recently been identified as host cells for malarial parasites, revealing a previously underappreciated host–parasite interaction. However, their extremely low abundance in peripheral blood has hindered progress, especially in elucidating the biological significance of parasitized erythroblasts (pEBs) in vivo. Methods: Here, we visualized pEBs in a murine model and established a method to increase their number in peripheral blood by immunizing mice with live Plasmodium yoelii 17XNL, followed by challenge with P. berghei ANKA. Results: Immunized mice were protected from cerebral malaria and survived longer, during which pEBs appeared in circulation and were detected using Giemsa-stained smears. All blood-stage parasite forms were identified within pEBs, including enucleating erythroblasts. Conclusions: This model enables in vivo/ex vivo analysis of pEB biology without bone marrow/spleen isolation, thus lowering technical/ethical barriers for the field. Full article
Show Figures

Figure 1

17 pages, 266 KB  
Article
Telling the Redemptive Story of Chinese Female Leprosy Victims in the Late Qing and Early Republican for Western Readers: The Missionaries’ Narrative in Without the Camp
by Donghua Zhou and Yan Xu
Religions 2025, 16(9), 1146; https://doi.org/10.3390/rel16091146 - 4 Sep 2025
Viewed by 763
Abstract
Leprosy relief efforts were a key part of the Christian mission of salvation in China. During the Anglo-American Protestant overseas missionary movement in the late 19th and early 20th centuries, many missionaries recorded stories about relief work of Chinese female lepers in Without [...] Read more.
Leprosy relief efforts were a key part of the Christian mission of salvation in China. During the Anglo-American Protestant overseas missionary movement in the late 19th and early 20th centuries, many missionaries recorded stories about relief work of Chinese female lepers in Without the Camp: The Journal of The Mission to Lepers in India and the East. First, the missionaries portrayed Chinese female lepers as marginalized figures, symbols of moral suffering and victims in need of salvation, reinforcing their religious mission and humanitarian spirit. Second, through the relief and conversion stories, the missionaries appealed to Anglo-American Christianity to participate in the overseas missionary movement and to fund the leprosy relief cause in China. Finally, the missionaries’ stories of converted Chinese women leprosy victims served as discourses for the spread of the gospel and civilization in China. Full article
(This article belongs to the Special Issue Chinese Christianity and Knowledge Development)
19 pages, 1910 KB  
Review
Hansen’s Disease in Ecuador: Current Status, Knowledge Gaps, and Research Priorities: A Literature Review
by Manuel Calvopiña, Juan S. Izquierdo-Condoy, Esteban Ortiz-Prado, Jorge Vasconez-Gonzalez, Lorena Vaca and Elías Guamán
Pathogens 2025, 14(8), 832; https://doi.org/10.3390/pathogens14080832 - 21 Aug 2025
Viewed by 2215
Abstract
Background: Hansen’s disease or leprosy is one of the 21 neglected tropical diseases (NTDs). In Ecuador, leprosy is considered eliminated as a public health problem; however, new cases are reported annually. Additionally, Mycobacterium leprae infection was detected in nine-banded armadillos across the country, [...] Read more.
Background: Hansen’s disease or leprosy is one of the 21 neglected tropical diseases (NTDs). In Ecuador, leprosy is considered eliminated as a public health problem; however, new cases are reported annually. Additionally, Mycobacterium leprae infection was detected in nine-banded armadillos across the country, suggesting a potential zoonotic reservoir. This literature review aims to provide an updated overview of the epidemiological situation of leprosy in Ecuador, identify knowledge gaps, and outline research priorities to support the development of a comprehensive national strategy for achieving zero autochthonous cases. Methods: This article analyses the current situation of leprosy in Ecuador based on international and national publications. A retrospective literature search using five international, regional, and national publications on leprosy published between 1954 and 2024 (70 years) with no restriction on language or publication date, was performed. Findings: Our review identified 28 publications with the earliest article dating back to 1954. Of these, 14 were published in international journals, 15 (53.6%) were in Spanish. Four nationwide studies documented leprosy cases across Ecuador’s three continental regions (Coast, Andes, and Amazon) with a predominance in the tropical coast. No cases have been reported from the Galápagos Islands. From 1983, Ecuador started multi-drug therapy. Data from the Ministry of Public Health (MoH) system identified 1539 incident cases, showing a significant decline in new cases from 2000 to 2024, with no cases in children. New cases detection rate by 100,000 inhabitants was 0.51 in 2019 according to the World Health Organization (WHO). No study has genotyped the Mycobacterium spp. in human cases, other animal species, or environment. According to the MoH, multibacillary leprosy accounts for 78.95% of diagnosed cases, with confirmation based on Ziehl–Neelsen staining and histopathology. No survey has assessed disabilities, knowledge, attitudes, and practices (KAP) or stigma related to leprosy. Research is needed on transmission routes, Mycobacterium genotyping, genetic susceptibility, and antibiotic resistance. BCG vaccination coverage fell to 75.3% in 2021. Cases are currently diagnosed and treated on an outpatient basis in large hospitals. Conclusions: This comprehensive review highlights persistent gaps in leprosy research and critical information, despite seven decades of documented cases in Ecuador. The disease is still endemic across the country, particularly at subnational level in the subtropics and tropics of the Pacific coast and the Amazon. There is a need for nationwide epidemiological research on reservoirs and the environment applying the One Health concept. Increased laboratory facilities and readily available official data are required to improve our understanding of leprosy in Ecuador. Strengthening community-level efforts is essential for Ecuador to meet the targets of the “WHO’s Towards Zero Leprosy: Strategy 2021–2030.” Full article
Show Figures

Figure 1

21 pages, 764 KB  
Article
PRACT-India: Practical Recommendations on Acne Care and Medical Treatment in India—A Modified Delphi Consensus
by Nina Madnani, Abir Saraswat, Anand Nott, Deepak Jakhar, Lalit Kumar Gupta, Malavika Kohli, Manas Ranjan Puhan, Prabhakar Sangolli, Rahul Nagar, Sanjay Kumar Rathi, Sanjeev Aurangabadkar, Satish DA, Seetharam KA, Sunil Dogra, Dhiraj Dhoot, Ashwin Balasubramanian, Saiprasad Patil and Hanmant Barkate
Antibiotics 2025, 14(8), 844; https://doi.org/10.3390/antibiotics14080844 - 20 Aug 2025
Viewed by 3893
Abstract
Background/Objectives: Acne vulgaris is a prevalent dermatological condition, yet clear, region-specific management guidelines, particularly for India’s diverse population, remain limited. Effective acne management extends beyond pharmacologic therapy, emphasizing proper skincare, patient education, and adherence strategies. This consensus aims to provide tailored, evidence-based recommendations [...] Read more.
Background/Objectives: Acne vulgaris is a prevalent dermatological condition, yet clear, region-specific management guidelines, particularly for India’s diverse population, remain limited. Effective acne management extends beyond pharmacologic therapy, emphasizing proper skincare, patient education, and adherence strategies. This consensus aims to provide tailored, evidence-based recommendations for optimizing acne treatment in the Indian context. Methods: A panel of 14 dermatology experts with ≥15 years of experience reviewed literature, real-world clinical practices, and patient-centric factors relevant to acne management in India. Using a modified Delphi process with two virtual voting rounds, 61 statements across seven clinical domains were evaluated. Consensus was defined as ≥75% agreement. Results: Topical retinoids remain the first-line therapy, with combination regimens (benzoyl peroxide or topical antibiotics) preferred to enhance efficacy and minimize antibiotic resistance. Hormonal therapies, including combined oral contraceptives and spironolactone, are recommended for females with resistant acne. Guidance includes individualized treatment plans, baseline investigations, and selection of appropriate topical and systemic agents. Special considerations for pregnancy and lactation prioritize maternal and fetal safety. Conclusions: This expert consensus provides practical, evidence-based recommendations for acne management in India, integrating pharmacological and non-pharmacological approaches. The tailored guidance supports individualized care, antibiotic stewardship, and improved treatment adherence, aiming to enhance patient outcomes nationwide. Full article
(This article belongs to the Section Antibiotic Therapy in Infectious Diseases)
Show Figures

Figure 1

16 pages, 1046 KB  
Systematic Review
Impacts of Mycobacterium leprae-Infection on Wild Populations of the Nine-Banded Armadillo (Dasypus novemcinctus) Species Complex: A Systematic Review
by Olivia F. Sciandra, Wesley M. Anderson, Sarah Zohdy and Kelly H. Dunning
Diversity 2025, 17(8), 582; https://doi.org/10.3390/d17080582 - 20 Aug 2025
Viewed by 1246
Abstract
Leprosy is a chronically infectious disease caused by infection with Mycobacterium leprae, or the more recently discovered Mycobacterium lepromatosis. In the Americas, wild armadillos of the Dasypus genus are natural hosts. A systematic review evaluated demographics and spatiotemporal patterns of infection [...] Read more.
Leprosy is a chronically infectious disease caused by infection with Mycobacterium leprae, or the more recently discovered Mycobacterium lepromatosis. In the Americas, wild armadillos of the Dasypus genus are natural hosts. A systematic review evaluated demographics and spatiotemporal patterns of infection with leprosy-causing bacteria in wild populations of the Dasypus novemcinctus species complex. The Web of Science Core Collection, Biosis Citation Index, Dissertations and Theses, and PubMed databases, in addition to Google Scholar, were searched on 16 April 2022. 158 records were recovered, and six peer-reviewed journal articles were selected and summarized that evaluated the effects of M. leprae-infection on mortality, reproduction, age structure, and sex ratio, in addition to seasonal, annual, and spatial infection patterns. Findings indicate that infection with M. leprae has the potential to impact reproduction, mortality, and population age structure. Studies found that the pathogen does not appear to cluster in populations, but consistent temporal findings were not recovered. A limitation of this review is that there was a single reviewer, which may introduce bias. A better understanding of the impacts and distribution of leprosy in wild populations would allow for improved management recommendations for nuisance Dasypus armadillos throughout their range and limit potential zoonotic transmission. Full article
(This article belongs to the Special Issue Ecology, Behavior, and Conservation of Armadillos)
Show Figures

Figure 1

32 pages, 3521 KB  
Review
A Systematic Review of Lifestyle Interventions for Neuropathy and Neuropathic Pain: Smoking Cessation
by Michael Klowak, Rachel Lau, Mariyam N. Mohammed, Afia Birago, Bethel Samson, Layla Ahmed, Camille Renee, Milca Meconnen, Ezra Bado, Aquilla Reid-John and Andrea K. Boggild
NeuroSci 2025, 6(3), 74; https://doi.org/10.3390/neurosci6030074 - 7 Aug 2025
Viewed by 1844
Abstract
Background: Neuropathic pain (NP), resulting from damage to the somatosensory nervous system, affects 7–10% of the global population and remains poorly managed despite available therapies. Smoking has been associated with increased pain severity and disease burden, yet its role in neuropathy/NP has not [...] Read more.
Background: Neuropathic pain (NP), resulting from damage to the somatosensory nervous system, affects 7–10% of the global population and remains poorly managed despite available therapies. Smoking has been associated with increased pain severity and disease burden, yet its role in neuropathy/NP has not been systematically reviewed. This systematic review synthesizes the existing literature on smoking status and its relationship with neuropathy/NP incidence, prevalence, and severity. Methods: The review was conducted in accordance with PRISMA guidelines and included studies that assessed smoking consumption, dependency, quantity, and cessation in individuals with neuropathy/NP. Summary estimates were stratified by exposure type, and pooled odds ratios and relative risks were calculated. Results: Across 62 studies comprising cohort, case–control, and cross-sectional designs, smoking was consistently associated with greater NP prevalence and pain severity. Smoking dependency was linked to increased incidence, while cessation was associated with reduced risk of NP. Despite considerable heterogeneity and risk of bias, particularly from subjective exposure measurement and inconsistent classification, this relationship remained statistically significant. Conclusions: Findings support the role of smoking as a modifiable risk factor in various etiologies of neuropathy/NP. Cessation may represent a low-cost, low-risk, low-tech adjunctive therapy; however, further robust cessation interventional trials are needed, particularly for less common infectious causes of chronic NP such as leprosy. Full article
Show Figures

Figure 1

22 pages, 1582 KB  
Systematic Review
The Magnitude and Patterns of Acquired Drug Resistance Mutations and Circulating HIV-1 Subtypes in HIV Patients in Tanzania, a Systematic Review and Meta-Analysis
by Shimba Henerico, Christa Kasang, Benson R. Kidenya, Deodatus Sabas, Violet D. Kajogoo, Gert Van Zyl, Wolfgang Preiser, Stephen E. Mshana and Samuel E. Kalluvya
Viruses 2025, 17(8), 1087; https://doi.org/10.3390/v17081087 - 6 Aug 2025
Viewed by 1137
Abstract
The emergence and spread of HIV drug resistance mutations (DRMs) pose a threat to current and future treatment options. To inform policy, this review aimed to determine the magnitude and patterns of DRMs in patients on ART in Tanzania. A systematic literature search [...] Read more.
The emergence and spread of HIV drug resistance mutations (DRMs) pose a threat to current and future treatment options. To inform policy, this review aimed to determine the magnitude and patterns of DRMs in patients on ART in Tanzania. A systematic literature search was conducted in MEDLINE through PubMed, Embase, and CINAHL up to December 2024. A total of 9685 HIV patients from 23 eligible studies were analyzed. The prevalence of virological failure in studies that used a threshold of >1000 and >400 copies/mL was 24.83% (95% CI: 17.85–32.53%) and 36.94% (95% CI: 24.79–50.00%), respectively. Major DRMs were observed at 87.61% (95% CI: 76.25–95.91%). A decrease in prevalence was observed in studies conducted from 2019, with a pooled prevalence of 62.15% (95% CI: 31.57–88.33%). The most frequently observed HIV-1 subtypes were subtype C at 36.20% (95% CI: 30.71–41.85%), A1 at 33.13% (95% CI: 28.23–38.20%), and subtype D at 16.00% (95% CI: 11.41–21.12%), while recombinant forms of the virus were observed at 13.29% (95% CI: 9.79–17.17%). The prevalence of DRMs against NRTIs and NNRTIs was significantly high, while that against INSTIs and PIs was low, supporting the continued use of PI- and INSTI-based regimens in Tanzania and the need for continued surveillance of DRMs. Full article
(This article belongs to the Special Issue Antiviral Resistance Mutations)
Show Figures

Figure 1

Back to TopTop